0001181431-13-018345.txt : 20130321
0001181431-13-018345.hdr.sgml : 20130321
20130321195711
ACCESSION NUMBER: 0001181431-13-018345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130321
FILED AS OF DATE: 20130321
DATE AS OF CHANGE: 20130321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: XANTHOPOULOS KLEANTHIS G
CENTRAL INDEX KEY: 0001283304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 13708854
MAIL ADDRESS:
STREET 1: 9050 CAMINO SANTA FE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 222-8041
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
rrd374969.xml
FORM 4
X0306
4
2013-03-21
0
0001017491
APRICUS BIOSCIENCES, INC.
APRI
0001283304
XANTHOPOULOS KLEANTHIS G
11975 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2013-03-21
2013-03-21
4
S
0
2864
2.50
D
81511
I
By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
/s/ Randy Berholtz by power of attorney for Kleanthis G. Xanthopoulos, Ph.D.
2013-03-21